6/20
08:05 am
viri
Virios Therapeutics, Inc. (NASDAQ: VIRI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.00 price target on the stock.
Low
Report
Virios Therapeutics, Inc. (NASDAQ: VIRI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.00 price target on the stock.
6/20
07:46 am
viri
Rating for VIRI
Medium
Report
Rating for VIRI
6/20
07:43 am
viri
Virios Therapeutics initiated with a Buy rating, $1 price target at Maxim
Medium
Report
Virios Therapeutics initiated with a Buy rating, $1 price target at Maxim
6/20
07:41 am
viri
Virios Therapeutics initiated with bullish view at Maxim
Medium
Report
Virios Therapeutics initiated with bullish view at Maxim